BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 11, 2007
View Archived Issues
Identification and preclinical characterization of a novel EGFR/SRC inhibitor SI-35
Read More
Peglyation increases and prolongs systemic exposure of irinotecan and its active metabolite in rats
Read More
Anticancer efficacy of ZK-EPO in preclinical ovarian cancer models and in patients with NSCLC
Read More
Recent patents describe new treatment options for cardiovascular diseases
Read More
New therapeutic options for cancer imparted in recent patent literature
Read More
deCODE launches clinical phase IIa trial of DG-051 in heart attack prevention
Read More
Bellicum receives Emerging Technology Fund award from the state of Texas
Read More
Adventrx completes enrollment in ANX-530 marketing-enabling study
Read More
Swissmedic to review ceftobiprole MAA for tissue infection, phase III results in HAP
Read More
Dara BioSciences and Point Therapeutics announce merger
Read More
DSMB gives positive recommendation for VIA-2291 trials
Read More
Promising preclinical data reported by Brainstorm for ALS therapy / News in Context
Read More
New orally active PAR-1 agonist described at Schering-Plough
Read More
Potent innate immune responses triggered by novel cationic lipid DNA complex adjuvant
Read More
Pooled trial data show agomelatine to be effective in severe depression
Read More
OXI-4503 well tolerated in ongoing phase I study
Read More
SLx-4090 lowers postprandial triglycerides, LDL-cholesterol in healthy men
Read More
Pharmexa reports update on GV-1001 clinical development
Read More
MK-0859 improves LDL- and HDL-cholesterol in large dyslipidemia study
Read More
Synergy seen with SQ-109 and rifampin against Mycobacterium tuberculosis
Read More
KP-1461 safe and well tolerated in phase I study in HIV patients
Read More
Dey launches Perforomist inhalation solution for long-term treatment of COPD
Read More
Recent Gruenenthal patents report novel analgesic agents
Read More
GlaxoSmithKline and Synta collaborate for STA-4783 in oncology
Read More
National Cancer Institute awards SBIR contract to Rules-Based Medicine
Read More